2026 NSGC Webinar Series Full Package
-
Register
- Non-member - $475
- Member - $400
This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that as webinars are released, they will be added to this package.
-
Contains 4 Component(s), Includes Credits
In this webinar, we will assess the upcoming implementation of genomes sequencing as the first-tier prenatal diagnostic test for all patients and consider the implications for non-invasive exome/genome sequencing. We will additionally consider the value of community and data sharing to drive this field forward.
Genome sequencing (GS) has emerged as a promising alternative to existing prenatal diagnostic methods. GS offers a single, high-resolution approach capable of simultaneously detecting a broad spectrum of genetic alterations below the detection threshold of CMA, impacting medical management in pregnancy, delivery, and neonatal care. In this webinar, we will assess the upcoming implementation of genomes sequencing as the first-tier prenatal diagnostic test for all patients and consider the implications for non-invasive exome/genome sequencing. We will additionally consider the value of community and data sharing to drive this field forward.
Presented by: NSGC Prenatal SIG
Jessica L. Giordano, MS, CGC
Date: February 4, 2026
Learning Objectives:
1. Examine the value of genome sequencing in prenatal diagnosis as a single-tier, comprehensive test for all patients
2. Assess benefits and limitations of different sequencing consenting and reporting strategies
3. Explore the future state of non-invasive exome/genome sequencing
4. Discuss the value of community and data sharing to move the field of prenatal diagnosis forwardContinuing Education Unit Approval:
The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for The future is here: Genome Sequencing as the first line prenatal diagnostic testing. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation -
Contains 4 Component(s), Includes Credits
This webinar will present recently published evidence-based, consensus driven practice recommendations for genetic testing of ataxias, focusing on an approach to clinical decision making, genetic counseling, and genetic testing.
This webinar will present recently published evidence-based, consensus driven practice recommendations for genetic testing of ataxias, focusing on an approach to clinical decision making, genetic counseling, and genetic testing. The presenters will highlight key updates from the publication, address common challenges, and discuss laboratory methodologies.
Presented by:
NSGC Neurology SIG
Amy Mook, MS, MPH, CGC
Michelle Rochman, MS, CGCDate: February 18, 2026
Learning Objectives:
1. Describe the rationale for creating standardized genetic testing recommendations
2. Review the process for developing evidence-based, consensus driven guidelines
3. Recommend an approach for evaluation and counseling for patients with a personal and/or family history ataxia
4. Discuss considerations for test selection and associated methodologiesContinuing Education Unit Approval:
The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for Practice Recommendations for Genetic Testing of Ataxias. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation -
Contains 4 Component(s), Includes Credits
Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.
Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.
Presented by:
Allison Harvey, MPH, CHES, Rhizome
Sara Pirzadeh-Miller, MS, CGC
Jaime Grund, MS, LGC
Stephanie Cohen, MS, LCGC
Charlie King, MGC, CGC
Kristen Shannon, MS, LCGC
Scott M. Weissman, MS, CGCDate: March, 16 2026
Learning Objectives:
1. Describe the core elements of the NSGC Business Case Toolkit for oncology genetic counseling services.
2. Describe how toolkit elements can be applied to your practice
3. Recognize the importance of clinical, financial, and operational metrics in developing a sustainable oncology genetics programContinuing Education Unit Approval:
The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for Making the Case: A Business Toolkit for Expanding Genetic Counseling in Oncology. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation -
Contains 4 Component(s), Includes Credits
Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.
Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.
Presented by:
Rozalia Valentine, MS, CGC
Brettne Frewin Elizabeth Spitzer, PhD
Kendra Schaa, ScM, CGC
Laura Godfrey Hendon, MA, MS, LCGCDate: March 18, 2026
Learning Objectives:
1. Illustrate the role of a genetic counselor in client-centered decision-making
2. Demonstrate how genetic counselors fit within the larger healthcare system
3. Review the wide differential and one center’s testing strategy for fetal cystic hygroma.
4. Examine the impact of severe intrafamilial variable expressivity in a “lethal” Mendelian disorder on patient expectations and coping.
5. Assess the limitations of current NMD vs NDD classification frameworks in DYNC1H1-related disorders and their impact on accurate diagnostic prognostication
6. Integrate patient and caregiver narratives into genetic counseling practice to inform communication, expectation-setting, and support.Continuing Education Unit Approval:
The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for NSGC Case Based Webinar - Part One. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation